引流淋巴结和肿瘤微环境中肿瘤特异性 CD8(+) T 细胞的功能亚群

Accumulating evidence demonstrates that tumor-specific CD8 + T cells in tumor-draining lymph nodes (TdLNs) act as an upstream reservoir of exhausted subsets within tumor microenvironment (TME). This reservoir primarily consists of progenitor exhausted CD8 + T (T PEX ) cells and newly defined tumor-specific memory subsets (T TSM ).

We propose that these two subsets work together to mediate the antitumor effects of PD-1/PD-L1 immune checkpoint blockade (ICB) in a spatiotemporal manner. Although PD-1/PD-L1 ICB monotherapy drives the proliferation and further differentiation of these subsets, it does not alter the programmed differentiation trajectory from T TSM cells to T PEX cells, ultimately leading to the development of terminally exhausted CD8 + T cells.

This phenomenon may partly explaining the frequent relapse in patients following initial ICB therapy. In this review, we focus on the phenotypic and functional heterogeneity of tumor-specific CD8 + T cells in both TdLNs and the TME and discuss the implications of these studies for ICB.

Our insights aim to illuminate new strategies for advancing tumor immunotherapies.